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Here we have used siRNAs and time-lapse epiﬂuorescence microscopy to examine the roles of various candidate mitotic
cyclins in chromatin condensation in HeLa cells. Knocking down cyclin A2 resulted in a substantial (7 h) delay in
chromatin condensation and histone H3 phosphorylation, and expressing an siRNA-resistant form of cyclin A2 partially
rescued chromatin condensation. There was no detectable delay in DNA replication in the cyclin A2 knockdowns, arguing
that the delay in chromatin condensation is not secondary to a delay in S-phase completion. Cyclin A2 is required for the
activation and nuclear accumulation of cyclin B1-Cdk1, raising the possibility that cyclin B1-Cdk1 mediates the effects of
cyclin A2. Consistent with this possibility, we found that chromatin condensation was tightly associated temporally with
the redistribution of cyclin B1 to the nucleus. Moreover, a constitutively nuclear cyclin B1 rescued chromatin condensation
in cyclin A2 knockdown cells. On the other hand, knocking down cyclin B1 delayed chromatin condensation by only
about one hour. Our working hypothesis is that active, nuclear cyclin B1-Cdk1 normally cooperates with cyclin A2 to
bring about early mitotic events. Because cyclin A2 is present only during the early stages of mitosis, we asked whether
cyclin B knockdown might have more dramatic defects on late mitotic events. Consistent with this possibility, we found
that cyclin B1- and cyclin B1/B2-knockdown cells had difﬁculty in maintaining a mitotic arrest in the presence of
nocodazole. Taken together, these data suggest that cyclin A2 helps initiate mitosis, in part through its effects on cyclin
B1, and that cyclins B1 and B2 are particularly critical for the maintenance of the mitotic state.
INTRODUCTION
Mitosis is one of the most spectacular events in cell biology.
In animal cells it begins with a nuclear event, the condensa-
tion of the chromosomes, and a cytoplasmic event, the sep-
aration of the centrosomes, during prophase. This is fol-
lowed by the breakdown of the nuclear envelope, which
marks the onset of prometaphase. The condensed chromo-
somes migrate to the center of the cell by metaphase, and
then the sister chromatids separate and move to opposite
sides of the cell during anaphase. Finally cytokinesis occurs,
the nuclear envelope reforms, the chromatin decondenses,
and the daughter cells progress into interphase (Morgan,
2007).
Mitosis is initiated by abrupt changes in the activity of
cyclin-dependent kinase (CDK) complexes. In their simplest
forms, these complexes are heterodimers made up of a reg-
ulatory cyclin subunit and a catalytic CDK subunit. In the
ﬁssion yeast Schizosaccharomyces pombe, a single CDK (Cdc2)
and a single cyclin (Cdc13) are sufﬁcient to drive the entire
cell cycle (Fisher and Nurse, 1996). In most other organ-
isms, multiple CDKs and cyclins are involved. For exam-
ple, in humans there are 30 cyclin genes and 21 CDK-
like genes. Eleven of the human cyclins (A1-2, B1-3, D1-3,
E1-2, and H) and ﬁve of the CDKs (CDK1, 2, 4, 6, 7) have
well-established roles as cell cycle regulators. Many of the
remaining cyclins and CDKs appear to be regulators of
transcription.
It still remains uncertain as to which of these many cyclins
regulate mitosis, whether different cyclins are dedicated to
different mitotic events, how much redundancy there is
between cyclin-CDKs, and how the functions of the mitotic
cyclin-CDKs are coordinated. Diverse lines of evidence now
support the hypothesis that cyclins A and B are the principal
mitotic cyclins in animals (Morgan, 2007), with a third class
of cyclin (B3 cyclins) being important for mitosis in some
species (Lehner and O’Farrell, 1990; Jacobs et al., 1998). The
CDK partners of the A-, B-, and B3 cyclins are CDK1 and
CDK2; the A-type cyclins can bind both CDK1 and CDK2,
the B-type cyclins partner with CDK1, and cyclin B3 binds
CDK2 (Nguyen et al., 2002).
In mammalian cell lines, cyclin A2 is ﬁrst detectable dur-
ing S-phase and is degraded during prometaphase (Pines
and Hunter, 1990, 1991; den Elzen and Pines, 2001; Geley et
al., 2001). Cyclin A2 shuttles dynamically between the cyto-
plasm and nucleus, with its steady-state concentration fa-
voring the nucleus (Pines and Hunter, 1991; Jackman et al.,
2002). Antibody injection experiments indicate that cyclin
A2 is required for DNA replication and, once replication is
complete, for mitotic entry (Pagano et al., 1992). Cyclins B1
and B2 become detectable slightly later and are degraded
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3149during metaphase (Minshull et al., 1990; Pines and Hunter,
1991; Jackman et al., 1995; Clute and Pines, 1999). Cyclin B1
shuttles between the cytoplasm and the nucleus and is pri-
marily cytoplasmic during interphase, concentrates at the
centrosome before mitosis, and then abruptly translocates
into the nucleus 5 min before nuclear envelope breakdown
(NEB) (Pines and Hunter, 1991; Ookata et al., 1992; Hagting
et al., 1999). This translocation is tightly correlated with
cyclin B1-Cdk1 activation (Gavet and Pines, 2010a, b). Cyclin
B2 is localized to the Golgi apparatus (Jackman et al., 1995;
Draviam et al., 2001). These localizations suggest that cyclin
B2 mediates Golgi disassembly and that cyclin A2, B1, or
both may mediate chromatin condensation and NEB.
Studies of knockout mice have shown that cyclins A2 and
B1 are both required for viability, but cyclin A1, whose
expression is conﬁned to germ cells, is required only for
male fertility, and the ubiquitously-expressed cyclin B2 is
dispensable (Murphy et al., 1997; Brandeis et al., 1998; Liu et
al., 1998). A mammalian cyclin B3 knockout has not been
reported yet, but because its expression is conﬁned to germ
cells (Nguyen et al., 2002) it seems unlikely to be a general
mitotic regulator in mammals. These ﬁndings are consistent
with the idea that cyclin A2, cyclin B1, or both, are the main
mitotic cyclins.
The advent of RNA interference (RNAi) approaches pro-
vided a way of testing this hypothesis and exploring the
redundancies and relationships among the cyclins. In HeLa
cells, a model system for the study of mitotic control that is
particularly amenable to RNAi, knocking down cyclin A2
causes a substantial delay in NEB (Fung et al., 2007; Gong et
al., 2007). The delay can be quantitatively accounted for by a
delay in the activation of cyclin B1-Cdk1 complexes (Fung et
al., 2007; De Boer et al., 2008) and in the translocation of
cyclin B1 to the nucleus (Gong et al., 2007; De Boer et al.,
2008). These ﬁndings suggest that NEB is promoted by
cyclin A2 through the intermediacy of nuclear cyclin B1.
This is reminiscent of the role cyclin A plays in mitosis in
Drosophila, where cyclin A acts by promoting the accumula-
tion and activation of cyclin B complexes (Jacobs et al., 1998;
Dienemann and Sprenger, 2004; Reber et al., 2006), and it
suggests that in both of these systems cyclin A-CDK, like the
CDK-activating kinase (CAK) cyclin H-CDK7, may regulate
mitosis mainly or exclusively through its effects on other
cyclin-CDKs.
This hypothesis presupposes that cyclin B1 is required for
mitosis in HeLa cells, and conﬂicting evidence has been
presented on this point. One group, using a short hairpin
RNA construct to knockdown cyclin B1 and assessing the
consequences by immunoblotting, kinase assays, and exam-
ination of ﬁxed cells, reported that cyclin B1 knockdown
prevents mitotic entry (Fung et al., 2007), indicating that
cyclin B1 is an essential regulator of mitosis. Our group,
using diced siRNA pools (d-siRNAs) and live-cell video
microscopy, found that knocking down cyclin B1, B2, or
both delays mitosis only slightly (Gong et al., 2007). This
suggests that even if cyclin B1 normally mediates NEB, its
function can be covered by cyclin A2. This interpretation is
consistent with the fact that a cyclin B1/A2 double knock-
down showed a longer delay in the onset of NEB than either
single knockdown showed (Gong et al., 2007). Qualitative
defects in late mitotic events (especially abnormalities in
cytokinesis) were common in cyclin B1/B2-double knock-
down cells, suggesting that even if cyclins B1 and B2 are not
essential for NEB, they are important in the later stages of
mitosis (Gong et al., 2007).
Here we have addressed the question of which cyclins are
required for another early mitotic event, chromatin conden-
sation. We also examined whether cyclins B1 and B2 might
be more critical during a spindle assembly checkpoint arrest,
where the mitotic state must be maintained long after cyclin
A2 has been degraded. We approached these questions in
synchronized HeLa cells, using diced siRNA pools to knock
down cyclins and time lapse ﬂuorescence microscopy to
assess the consequences. Our ﬁndings underscore the im-
portance of cyclin A2 in the initiation of mitosis, suggest that
cyclin A2’s effects on chromatin condensation are at least
partly mediated by cyclin B1, and indicate that cyclin B1 and
cyclin B2 are important for the maintenance of a mitotic
arrest in the presence of nocodazole.
MATERIALS AND METHODS
DNA Constructs and d-siRNA Pools
Cyclin expression constructs and the tdimer2-RFP mitotic biosensor (Jones et
al., 2004) were generated as described (Gong et al., 2007). A ﬂuorescently-
tagged histone H2B was constructed by amplifying the open reading frame of
human histone H2B from a HeLa cDNA library and cloning it into pEYFP-N1
or pECFP-N1 (Clontech, Palo Alto, CA) using XhoI and SalI. Diced siRNA
pools were generated from 600 base pairs dsRNAs derived from a cyclin
coding region or 3-UTR, or from an irrelevant ﬁreﬂy luciferase (GL3) coding
region, using recombinant human Dicer as described (Myers and Ferrell, 2005;
Gong et al., 2007), or using TurboDicer (Genlantis, San Diego, CA).
Cell Culture, Transfection, and UV/Drug Treatments
HeLa cells (ATCC, Manassas, VA) were cultured at 37°C and 5% CO2 in
DMEM, supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100
g/ml streptomycin, and 4 mM glutamine (all from Invitrogen, Carlsbad,
CA). Cells were synchronized by double thymidine block (2 mM thymidine
for 18 h, release for 9 h, 2 mM thymidine for 17 h). Cells were cotransfected
with a total of 25 nM d-siRNAs plus 10 ng of a histone H2B expression
construct alone, or 5 ng of the histone H2B expression construct with 10 ng of
the WT- or NLS-cyclin B1-YFP. For the ﬂow cytometry and DNA damage
experiments, cells were transfected with 25 nM d-siRNAs only. All transfec-
tions were carried out using GeneSilencer (Genlantis) during the ﬁrst release
from thymidine treatment. For DNA damage experiments, cells were released
from thymidine block into growth media for 4 h, washed once with PBS, subject
to UV irradiation at 50 J/cm2 in a UV Stratalinker 1800 (Stratagene/Agilent,
Santa Clara, CA), and then replaced with growth media for 4 h before collection
for immunoblotting. For nocodazole treatments, cells were released into growth
media containing 100–200 ng/ml nocodazole (Sigma Aldrich, St. Louis, MO).
Flow Cytometry
Trypsinized cells were ﬁxed in 2% paraformaldehyde followed by ice-cold
100% methanol for at least 20 min. Cells were incubated with anti–phospho-
histone H3 antibody (mouse monoclonal, 1:200 dilution, Upstate Biotech/
Millipore, Billenica, MA), followed by goat anti-mouse Alexa 647 secondary
antibody (1:100 dilution, Invitrogen), both in PBS containing 1% BSA, 0.1%
Triton X-100. Cells underwent a ﬁnal staining with a solution containing 50
g/L propidium iodide and 0.1 mg/ml RNase A in 1% BSA in PBS. At least
1.4  104 cells were analyzed using the LSR ﬂow cytometer (Becton Dickin-
son, Franklin Lakes, NJ), and data were collected using CellQuest software
(Becton Dickinson) and analyzed using FlowJo software.
Microscopy and Image Analysis
Cells were imaged using the Axon ImageXpress 5000A or the ImageXpress
Micro (Molecular Devices, Sunnyvale, CA). Images were captured at one
frame per 3–5 min for 14–18 h with a 10, 20, or 40 objective lens. Image
analysis was performed using sequences of images compiled by the ImageX-
press Console (Molecular Devices), ImageJ, and CellProﬁler. Image analysis
and two-line curve ﬁtting scripts were written in MatLab.
Western Blot Analysis
Cells were resuspended in lysis buffer (100 mM Tris [pH 7.9], 0.42 M NaCl,
0.5% Triton X100, 1 mM EDTA, 1 mM EGTA), vortexed for 10 s every 10 min
for 1 h, and microcentrifuged at maximum speed. Total protein in the super-
natants were quantiﬁed using the BCA Assay kit (Pierce/Thermo, Rockford,
IL). At least 8 g of total protein was subject to 8% SDS-PAGE and transferred
to PVDF membrane (Millipore). Dry membranes were probed using primary
antibodies speciﬁc for cyclin A2, cyclin B1 (Santa Cruz Biotechnology, Santa
Cruz, CA, sc-751, sc-752), phospho-histone H3 (Upstate Biotech), all at 1:1000
dilutions. Anti–phospho-Chk1 and anti-Chk1 antibodies were used according
to manufacturer’s instructions (Cell Signaling Technology, Danvers, MA).
Membranes were then probed with horseradish peroxidase (HRP)-conjugated
secondary antibodies at 1:2500 dilutions (Amersham/GE, Piscataway, NJ) in
D. Gong and J. E. Ferrell, Jr.
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Star HRP substrate (Bio-Rad, Hercules, CA) or SuperSignal West Dura or Femto
Maximum Sensitivity Substrate (Pierce). Chemiluminescence was detected using
GelDoc EQ (Bio-Rad) and quantiﬁed using QuantityOne 4.5.0 (Bio-Rad).
RESULTS
Knocking Down Cyclin A2 Delays Chromatin
Condensation
We developed a quantitative live-cell assay for chromatin
condensation, using HeLa cells transiently expressing a ﬂu-
orescent histone (H2B-YFP) (Kanda et al., 1998) and taking
advantage of the fact that when chromatin condensation
begins, the nuclear H2B-YFP ﬂuorescence changes from uni-
form to variable (Figure 1A). The SD of the nuclear H2B-YFP
ﬂuorescence per pixel over the nucleus can be taken as a
quantitative measure of how condensed the chromatin is;
the higher the SD, the more condensed the chromatin. As
shown in Figure 1B, the ﬂuorescence SD typically took a
sharp turn upward 10 min before NEB. We estimated the
time at which chromatin condensation began by ﬁtting two
straight lines to the ﬂuorescence variability data and inter-
polating the time at which the two lines intersected. The
timings calculated by this method remained consistent be-
tween time-lapse images generated using 10, 20, or 40
objective lenses and agreed well with subjective estimates of
the onset of chromatin condensation.
To study the effects of cyclin knockdown on the timing of
chromatin condensation, we used diced siRNA pools (d-
siRNAs) generated against 600-bp stretches of the cyclin
coding sequence. Diced siRNAs were chosen because of
their low propensity for off target effects (Myers et al., 2006),
their lack of interference with endogenous miRNA process-
ing pathways (Grimm et al., 2006), and their record of spec-
iﬁcity and efﬁcacy in previous screens and studies (Myers et
al., 2003; Liou et al., 2005; Myers and Ferrell, 2005; Brandman
et al., 2007; Gong et al., 2007). HeLa cells were partially
synchronized by thymidine treatment, released from the
ﬁrst thymidine block and transfected with control or cyclin
d-siRNA pools, and then blocked again in S-phase by thy-
midine treatment. Five hours after the release from the sec-
ond thymidine block (24 h post transfection), we began
monitoring chromatin condensation by automated epiﬂuo-
rescence microscopy.
To assess the extent of cyclin knockdown we collected
cells at various times after release from the thymidine block,
lysed them, and subjected the lysates to immunoblotting for
cyclins A2 and B1. In the GL3-transfected control cells, the
levels of cyclin A2 and cyclin B1 rose steadily after release
from the thymidine block, peaked at 10 h, and then fell
(Figure 1C). The d-siRNA pools effectively and speciﬁcally
knocked down the intended cyclin target(s) for at least 14 h
and typically until at least 20 h after release from thymidine,
without any detectable cross-silencing (Figure 1, C and D).
The extent of silencing was high; residual cyclin levels were
typically 0–25% of basal levels. Given that some of the
residual cyclin was undoubtedly contributed by nontrans-
fected cells, the residual cyclin levels in the transfected cells
must have been smaller still.
Knocking down cyclin A2 delayed the onset of chromatin
condensation by several hours (Figure 1D, red points); more
than half of the control GL3 knockdown cells had undergone
chromatin condensation by 12 h post-release, whereas 10%
of the cyclin A2 knockdown cells had undergone chromatin
condensation at that time and only a third of the cyclin A2
knockdown cells had undergone chromatin condensation by
19 h. Cyclin B1 knockdown resulted in a delay of about one
hour (Figure 1D, green points), and knocking down both
cyclin A2 and cyclin B1 virtually abolished chromatin con-
densation (Figure 1D, blue points). The delay in chromatin
condensation seen in the cyclin A2 knockdown cells, and the
further delay in the cyclin A2/B1 double knockdown cells,
were reproducible from well to well and from experiment to
experiment (Figure 1E). These results suggest that cyclin A2
is required for the initiation of mitotic chromatin condensa-
tion and that there is redundancy between cyclin A2 and
cyclin B1. These ﬁndings agree well with previous func-
tional studies which showed that microinjection of cyclin A2
antibodies blocks mitosis (Pagano et al., 1992), microinjection
of a cyclin A2 function-blocking peptide (derived from p21
Cip1, which is a high-afﬁnity inhibitor of cyclin A2-CDK2
and cyclin E-CDK2, a moderate afﬁnity inhibitor of cyclin
B-CDK1, and a putative activator of cyclin d-CDK4/6 com-
plexes [Gu et al., 1993; Cheng et al., 1999; Sherr and Roberts,
1999]) into prophase cells results in the decondensation of
previously condensed chromatin (Furuno et al., 1999), and
that a similar inhibitor blocks mitosis in Xenopus egg extracts
(Guadagno and Newport, 1996).
To determine whether the delay in chromatin condensa-
tion in cyclin A2 knockdown cells might be due to off-target
effects rather than cyclin A2 knockdown per se, we gener-
ated d-siRNAs from a different region in the cyclin A2
cDNA, the 3 untranslated region (3-UTR). The cyclin A2
3-UTR d-siRNAs knocked down the endogenous cyclin
A2 (Figure 2A) and delayed chromatin condensation (Figure
2B, red points). Expression of cyclin A2 from a construct that
lacked the 3-UTR and hence was unaffected by the 3-UTR
d-siRNA, partially reversed the delay, restoring the timing
of chromatin condensation to that seen in cells transfected
with a control (GL3) d-siRNA plus the same 3-UTR-less
cyclin A2 (Figure 2B, blue points vs. gray points), although
not to that seen in GL3 d-siRNA cells cotransfected with a
sham rescue construct (Figure 2B, gray points vs. black
points). These ﬁndings argue that the delay in the initiation
of chromatin condensation seen in the cyclin A2 knockdown
cells is not due to off-target effects.
Histone H3 Phosphorylation Is Delayed in Cyclin A2
Knockdown Cells
Fung and coworkers reported that cyclin B1 knockdown was
just as effective as cyclin A2 knockdown in suppressing the
mitotic phosphorylation of histone H3 at Ser 10 (Fung et al.,
2007). Because histone H3 phosphorylation generally corre-
lates well with chromatin condensation (Hendzel et al.,
1997), and because we saw little effect of cyclin B1 knock-
down on the timing of chromatin condensation (Figure 1),
we set out to determine what effects our cyclin knockdowns
had on histone H3 phosphorylation.
We synchronized HeLa cells, transfected them with cyclin
d-siRNAs, and collected them at various times after release
from thymidine for analysis by ﬂow cytometry and immu-
noblotting. Cyclin knockdown was veriﬁed by Western blot
analysis (Figure 3A). There was a small delay in the accu-
mulation of phospho-histone H3 in cyclin B1 knockdown
cells (Figure 3, B and C). There was a more dramatic delay in
the appearance of phospho-histone H3 in the cyclin A2
knockdown cells and a further delay in the cyclin A2/B1
double knockdown cells (Figure 3, B and C). Thus the his-
tone H3 phosphorylation data are consistent with the mi-
croscopy data shown in Figure 1; cyclin B1 knockdown had
a small effect, cyclin A2 knockdown had a larger effect, and
cyclin A2/B1 double knockdown had the largest effect.
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DNA Replication or on Replication-Associated Activation
of the DNA Checkpoint Response
Previous work has demonstrated that cyclin A2 regulates
S-phase events (Pagano et al., 1992). Thus one possible ex-
planation for the delay in chromatin condensation seen in
cyclin A2 knockdown cells could be slowed DNA replica-
tion, with delay in chromatin condensation being secondary
to the activation of the DNA replication checkpoint. How-
ever, recent studies found no gross delay in DNA replica-
Figure 1. The effects cyclin A2 and cyclin B1 d-siRNAs on the timing of chromatin condensation in HeLa cells. (A–D) HeLa cells were
synchronized by double thymidine block and transfected with histone H2B-YFP and GL3 or cyclin d-siRNAs during the ﬁrst release from
thymidine. (A) Sixteen frames from a time-lapse movie of a mitotic HeLa cell expressing histone H2B-YFP. Time stamps (hh:mm) indicate
time after release from double thymidine block. (B) Scoring the onset of mitotic chromatin condensation for three cells. The red points
correspond to the cell pictured in A. (C) Time course of cyclin levels in d-siRNA–treated synchronized HeLa cells as assessed by
immunoblotting. (D) Timing of chromatin condensation in d-siRNA–treated HeLa cells. The immunoblot (inset) shows cyclin levels in
d-siRNA treated cells at 20 h after release from double thymidine block. (E) Final cumulative % chromatin condensation events 20 h after
release from double thymidine block. Data are expressed as means  SE from 4 movies from two experiments.
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Molecular Biology of the Cell 3152tion, as judged by propidium iodide staining and ﬂow cy-
tometry in cyclin A2 knockdown cells released from double-
thymidine arrest (Fung et al., 2007; Gong et al., 2007). We
corroborated this result. As shown in Figure 4A, DNA pro-
ﬁles at the time of release were normal in all of the knock-
down cells, indicating that the siRNA treatments did not
affect synchronization. In all of the control and cyclin knock-
down cells, DNA replication was evident by 5 h post-release,
with the majority of the cells present in a peak with an
intermediate S-phase DNA content and a smaller fraction of
the cells present in a G1-phase DNA-content peak. By 8 h
post-release, the S-phase peak had shifted to a G2/M DNA
content in both the control and cyclin knockdown cells. By
10 h post-release, most or the control and cyclin B1 knock-
down cells had completed mitosis, with their DNA content
returning to G1-phase levels, whereas most of the cyclin
A2-knockdown and cyclin A2/B1 double-knockdown cells
still had a G2/M DNA content, presumably because they
were delayed in completing mitosis. Thus, in agreement
with previous reports (Fung et al., 2007; Gong et al., 2007),
DNA replication was not grossly slowed in the cyclin A2
knockdown cells, suggesting that the delay in chromatin
condensation was not secondary to activation of the DNA
replication checkpoint.
A more direct way to assess whether the DNA replica-
tion/damage checkpoint was activated is phospho-Chk1
(pChk1) immunoblotting; if checkpoint activation were re-
sponsible for the delay in mitotic entry seen in cyclin A2
knockdown cells, we would expect the pChk1 signal to be
stronger or more sustained in the cyclin A2 knockdown cells
than in control cells. To see whether this was the case, HeLa
cells were synchronized by thymidine block, released and
Figure 2. An RNAi-resistant form of cyclin A2 rescues chromatin
condensation in cyclin A2 knockdown cells. (A–B) HeLa cells were
synchronized by double thymidine block and transfected with his-
tone H2B-YFP, one of two diced siRNA pools (GL3 d-siRNAs or
d-siRNAs targeted to the 3UTR of cyclin A2), and one of two rescue
constructs (a sham YFP rescue construct or a cyclin A2-YFP rescue
construct lacking the 3UTR). (A) Cyclin levels of d-siRNA–treated
HeLa cells at 20 h after release from double thymidine block, as
assessed by immunoblotting. (B) Timing of chromatin condensation
in cells treated with d-siRNAs plus a cyclin A2 or YFP rescue
construct. Chromatin condensation was assessed by automated
time-lapse epiﬂuorescence microscopy. The bar graph (inset) shows
the ﬁnal cumulative % chromatin condensation events at 19 h after
release from double thymidine block. Data are expressed as
means  SE from 6 movies from two experiments.
Figure 3. Cyclin A2 knockdown delays histone H3 phosphoryla-
tion. (A–C) HeLa cells were synchronized by double thymidine
block and transfected with GL3 or cyclin d-siRNAs. (A) At 14 h after
release from thymidine block, cyclin knockdown was veriﬁed by
immunoblotting. Levels of histone H3 phosphorylation were as-
sessed by immunoblotting (B) and ﬂow cytometry (C). For C, data
are expressed as means  SE from three independent experiments.
Mitotic Functions of Cyclins
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blocked again by thymidine treatment, and then released
from the second thymidine block. At various times after
release, we examined the cells by microscopy to gauge
whether they were progressing into mitosis and then lysed
the cells and subjected the lysates for immunoblotting. The
knockdown of cyclin A2 was 70% (Figure 4B). This extent
of knockdown was sufﬁcient to almost completely prevent
the cyclin A2 knockdown cells from entering mitosis during
the ﬁrst 12 h post-release.
At the time of release, both the GL3 and cyclin A2 knock-
down cells showed low levels of pChk1 immunoreactivity,
25% of the levels seen in the positive-control UV-treated
cells (Figure 4B). The pChk1 signal increased by 4–6 h
post-release, presumably due to activation of the checkpoint
during DNA replication, and then fell over the next several
hours (Figure 4B). The pChk1 signal did not appear to be
elevated or prolonged in the cyclin A2 knockdown cells
(Figure 4B). These ﬁndings argue against the possibility that
activation of the DNA replication/damage checkpoint is
responsible for the delay in mitotic entry seen in cyclin A2
knockdown cells.
Chromatin Condensation Coincides with the
Translocation of Cyclin B1 to the Nucleus
There are at least two plausible interpretations of the knock-
down data. It is possible that cyclin A2 is directly responsi-
ble for chromatin condensation and that cyclin B1 can pro-
vide a backup function (although after a substantial delay,
perhaps because cyclin B1’s accumulation in the nucleus is
delayed in cyclin A2 knockdown cells [Gong et al., 2007; De
Boer et al., 2008]). Alternatively, it is possible that cyclin B1
is normally responsible for chromatin condensation, with
cyclin A2 providing a backup function. To further explore
the possibility that cyclin B1 might normally trigger chro-
matin condensation, we looked at the timing of chromatin
condensation versus cyclin B1 translocation.
We cotransfected H2B-CFP and cyclin B1-YFP into syn-
chronized HeLa cells and followed chromatin condensation
and cyclin B1 nuclear accumulation by epiﬂuorescence
video microscopy. Typically cyclin B1-YFP redistributed
from the cytoplasm to the nucleus over the course of 10
min (Figure 5A). NEB occurred within a few minutes of the
completion of this redistribution, allowing the cyclin B1 to
spread back into the cytoplasm, causing the intensity of the
ﬂuorescence in the region of the nucleus to fall by about half
(Figure 5A).
For each cell expressing both H2B-CFP and cyclin B1-YFP,
we calculated the time when chromatin condensation com-
menced as described in Figure 1B and the time at which
cyclin B1-YFP began to accumulate in the nucleus by a
similar automated curve-ﬁtting procedure. Figure 5B shows
chromatin condensation and nuclear translocation data for
three typical cells. The absolute timing of mitotic entry was
highly variable from cell to cell, but chromatin condensation
and cyclin B1-YFP nuclear translocation were always nearly
coincident (Figure 5C), with no signiﬁcant systematic lag
between the two events (Figure 5D). These ﬁndings are
consistent with the hypothesis that the entry of active cyclin
B1-Cdk1 complexes into the nucleus rapidly brings about
chromatin condensation. Alternatively, the two events could
be independent of each other but tightly dependent upon
some other event (such as the activation of cyclin A2-Cdk2
or cyclin A2-Cdk1).
Nuclear Cyclin B1 Can Substitute for Cyclin A2
To further explore the possibility that cyclin A2 brings about
chromatin condensation through its effects on cyclin B1, we
examined whether the expression of nuclear cyclin B1 could
rescue the delay in chromatin condensation seen in cyclin
A2 knockdown cells. We expressed cyclin A2 d-siRNAs plus
either wild-type cyclin B1-YFP (WT-B1), a constitutively nu-
clear cyclin B1-YFP (NLS-B1), or a sham YFP rescue con-
struct in synchronized HeLa cells, and monitored chromatin
condensation with histone H2B-CFP and other mitotic
events with a mitotic biosensor (MBS) (Jones et al., 2004).
Cyclin immunoblots showed that cyclin A2 was knocked
down in all of the cyclin A2 d-siRNA-transfected cells (Fig-
ure 6A). The transfected WT-cyclin B1-YFP construct was
expressed at slightly higher levels than the endogenous
cyclin B1 protein, and transfected NLS-cyclin B1-YFP pro-
tein was expressed at lower levels (Figure 6A). The cyclin A2
knockdown cells exhibited a substantial delay in chromatin
condensation (Figure 6B, green points). Expression of WT-
cyclin B1-YFP partially rescued chromatin condensation
(Figure 6B, yellow points), and NLS-cyclin B1-YFP com-
pletely rescued it (Figure 6B, red points). Neither the WT-
cyclin B1-YFP nor the NLS-cyclin B1-YFP protein altered the
Figure 4. Cyclin A2 knockdown does not delay DNA replication or activate the
DNA replication/damage checkpoint. (A) Propidium iodide ﬂow cytometry of
cells knocked down with control (GL3) or cyclin d-siRNAs, at various times after
release from double thymidine block. (B) Immunoblots of cells collected at
various times after release from double thymidine block and probed for phos-
pho-Chk1 (pChk1), total Chk1, and cyclin A2. UV denotes cells irradiated with
UV light (50 J/cm2) at four hours after release and then collected at eight hours.
D. Gong and J. E. Ferrell, Jr.
Molecular Biology of the Cell 3154timing of chromatin condensation in the cells treated with
GL3 d-siRNAs (Figure 6B, black, blue, and gray points).
Knocking down cyclin A2 causes delays in early mitotic
events—NEB (Gong et al., 2007) and chromatin condensation
(Figures 1, 2, and 6B)—and it also causes defects in mitotic
progression (Gong et al., 2007). This raises the question of
whether NLS-cyclin B1-YFP rescues the defects in mitotic pro-
gression as well as it rescues chromatin condensation. Approx-
imately 60% of the cells transfected with GL3 d-siRNAs under-
went mitosis during the period of the microscopy (5–19 h after
release from the second thymidine block), and mitosis was
qualitatively and quantitatively normal in 90% of the cells
that underwent mitosis (Figure 6). In the cyclin A2 knockdown
cells subjected to a sham rescue, the number of mitotic cells
dropped, and the proportion of the mitotic cells that under-
went normal mitosis fell from 90–60%. However, although
the number of cells entering mitosis was restored to normal
in the NLS-cyclin B1-YFP-transfected cells, the proportion of
the mitoses that were normal was not restored (Figure 6C).
These data suggest that although NLS-cyclin B1-YFP can
rescue the timing of chromatin condensation, it cannot com-
pletely replace cyclin A2 function for normal mitotic pro-
gression. This could be because of some required function of
cyclin A2 per se, or because the tempo of cyclin B1-Cdk1
nuclear import is different in NLS-cyclin B1-YFP–expressing
cyclin A2-knockdown cells compared with control cells.
Cyclins B1 and B2 Are Required to Maintain Mitosis in
the Presence of Nocodazole
The present study and our previous work (Gong et al., 2007)
focus on early mitotic events—chromatin condensation and
NEB, respectively—and found relatively subtle phenotypes
in cyclin B1 knockdown cells. The previous study also
hinted that both cyclins B1 and B2 might be more important
for later mitotic events, because cyclin B1/B2 double knock-
down cells displayed a high incidence of late mitotic abnor-
malities (Gong et al., 2007). This hypothesis is also suggested
by the fact that cyclin A2 is degraded before cyclins B1 and
B2 (Pines and Hunter, 1991; Clute and Pines, 1999), and so
the phosphorylations carried out by cyclin A2-Cdks may
have turned over by the later parts of mitosis. If so, then
lengthening the duration of mitosis might increase the se-
verity of the cyclin B1/B2 knockdown phenotypes.
To test this hypothesis, we treated cells with the microtu-
bule depolymerizing drug nocodazole. Nocodazole-treated
cells progress through interphase with near-normal timing
and undergo NEB normally, but then arrest in promet-
aphase due to the inability of the cell to satisfy the spindle
assembly checkpoint. Nocodazole-arrested cells degrade
their cyclin A2 normally but do not degrade cyclin B1 or B2.
They can maintain a spindle assembly checkpoint arrest for
many hours. Eventually nocodazole-treated cells sometimes
Figure 5. Chromatin condensation is tempo-
rally associated with the translocation of cy-
clin B1-YFP to the nucleus. HeLa cells were
synchronized by double thymidine block and
transfected with histone H2B-CFP and cyclin
B1-YFP. (A) Six frames from a time lapse
movie showing cyclin B1-YFP translocation
just before nuclear envelope breakdown
(NEB). (B) Chromatin condensation (red) and
cyclin B1-YFP translocation for three typical
cells. Chromatin condensation is inferred
from the SD of the nuclear histone H2B-CFP
ﬂuorescence. Cyclin B1-YFP translocation is
inferred from the integrated intensity of the
nuclear cyclin B1-YFP. Both quantities are ex-
pressed relative to their maximum and mini-
mum values for each cell. (C) Correlation be-
tween the timing of cyclin B1-YFP nuclear
translocation and chromatin condensation.
(D) Histogram of the time differences between
chromatin condensation and cyclin-YFP nu-
clear translocation.
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degradation of B-type cyclins (Brito and Rieder, 2006). Thus,
cyclin B1 and/or B2 knockdown cells might have difﬁculty
maintaining the mitotic state in the presence of nocodazole.
Alternatively, other kinases active during a spindle assem-
bly checkpoint arrest, such as p38 MAP kinase and Erk1/2
(Minshull et al., 1994; Wang et al., 1997; Takenaka et al., 1998;
Eves et al., 2006; Rosner, 2007), might be able to maintain the
arrest in the absence of the B-type cyclins.
To examine these possibilities, we synchronized HeLa
cells, transfected them with the MBS plus control (GL3),
cyclin B1, and/or cyclin B2 d-siRNAs, and released the cells
from thymidine block into normal growth medium or
growth medium containing 100 ng/ml nocodazole. We then
determined the timing of NEB (Figure 8A) and how long the
mitotic state was maintained (Figures 7 and 8). Figure 7A
shows an example of a GL3 transfected cell in the absence of
nocodazole. The cell broke down its nuclear envelope, as
indicated by the dispersal of the MBS from the nucleus to the
whole of the cell, and began reforming its nucleus, as indi-
cated by the reaccumulation of the MBS near the center of
the cell, within 40–45 min (Figure 7A). Cyclin B1, cyclin B2,
and cyclin B1/B2 double knockdown cells also generally
completed mitosis in the absence of nocodazole, with cyclin
B1 and cyclin B1/B2 knockdown cells taking slightly longer
to complete mitosis (data not shown).
In the presence of nocodazole, the control GL3 cells and
cyclin B2 knockdown cells underwent NEB and maintained
a round mitotic morphology throughout the duration of the
time-lapse movie (Figure 7B and data not shown). In con-
trast, many of the cyclin B1 and cyclin B1/B2 double knock-
down cells underwent NEB, stayed round for a short period
of time, and then ﬂattened back out, with the nuclear enve-
lope reforming and the MBS relocalizing to the nucleus
(Figure 7, C and D). Some of these cells appeared to have
attempted cytokinesis and failed, resulting in abnormal
multi-lobed interphase nuclei (Figure 7C).
About half (48%) of the cyclin B1 knockdown cells and
61% of the cyclin B1/B2 double knockdown cells exited
mitosis before the end of the video, whereas mitotic exit was
rarely seen in GL3 cells (0.5%) and cyclin B2 knockdown
cells (6%) (Figure 8B). Spindle assembly checkpoint failure
was not seen in cyclin A2 knockdown cells (Figure 8B). The
median duration of the nocodazole-induced mitotic arrest
was more than6hi nt h eG L 3a n dcyclin B2 knockdown
cells, 4.3 h in the cyclin B1 knockdown cells, and 2.2 h in the
cyclin B1/B2 double knockdown cells. Thus, the ability to
maintain a mitotic arrest was compromised in the cyclin B1
Figure 6. Constitutively-nuclear cyclin B1 rescues the chromatin condensation
delay in cyclin A2 knockdown cells. (A-C) HeLa cells were synchronized by double
thymidine block and cotransfected with both the histone H2B-CFP and the mitotic
biosensor (MBS), one d-siRNA pool (GL3 or cyclin A2 d-siRNAs), and one rescue
construct (sham YFP, wild type [WT] cyclin B1-YFP, or a constitutively-nuclear
version of cyclin B1-YFP [NLS-cyclin B1-YFP]). (A) Cyclin levels as assessed by
immunoblotting. (B) The timing of chromatin condensation in cells expressing
histone H2B-YFP using automated time-lapse epiﬂuorescence microscopy. (C) Final
% mitosis chromatin condensation and assessment of mitotic progression pheno-
types using the MBS.
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double knockdown cells. This implies that both cyclin B1
and cyclin B2 help maintain mitosis in nocodazole-treated
cells, with the role of cyclin B2 being most apparent when
cyclin B1 is knocked down.
DISCUSSION
Here we began by addressing the question of which cyclins
are required for an early mitotic event, chromatin conden-
sation. Using diced siRNA pools and ﬂuorescence video
microscopy, we found that knocking down cyclin A2 delays
chromatin condensation (Figure 1), indicating that cyclin A2
directly or indirectly regulates the process and corroborating
previous microinjection studies with cyclin A2 antibodies
and p21-derived cyclin A2 inhibitors (Pagano et al., 1992;
Furuno et al., 1999). The delay in chromatin condensation
was also seen with a second d-siRNA pool, derived from the
cyclin A2 3-UTR, and was partially rescued by expressing
an RNAi-resistant cyclin A2 construct (Figure 2), arguing
that the delay is due to cyclin A2 knockdown rather than an
off-target effect. Cyclin A2 knockdown also delayed the on-
set of histone H3 phosphorylation, an event that correlates
with chromatin condensation.
In principle the delay in chromatin condensation seen in
cyclin A2 knockdown cells could be due to a delay in DNA
replication and a consequent activation of the DNA replica-
tion/damage checkpoint response. However, we found no
evidence for a delay in DNA replication or for prolonged
activation of the DNA replication checkpoint in cyclin A2
knockdown cells (Figure 4). The simplest interpretation of
these results is that cyclin A2 is a mitotic regulator, as
previously proposed (Swenson et al., 1986; Pagano et al.,
1992; Guadagno and Newport, 1996; Furuno et al., 1999;
Fung et al., 2007; Gong et al., 2007; Deibler and Kirschner,
2010). The alternative possibility is that even though cyclin
Figure 7. Defects in the spindle assembly checkpoint in cyclin B1/B2 knockdown cells. (A–D) HeLa cells were synchronized by double
thymidine block, transfected with the mitotic biosensor (MBS) plus GL3 or cyclin d-siRNAs, and released into growth media containing the
microtubule poison, nocodazole. (A) A control GL3-transfected cell undergoes a qualitatively normal mitosis in 40 min, whereas (B) GL3
cells arrest in mitosis in the presence of nocodazole. (C) Cyclin B1 knockdown cells round up in the presence of nocodazole but eventually
ﬂatten out and reform their nuclear envelopes. (D) Cyclin B1/B2 double knockdown cells ﬂatten sooner than cyclin B1 single knockdown
cells. Times indicate minutes relative to NEB.
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small proportion of the DNA remains unreplicated and
brings about enough activation of the DNA replication
checkpoint to block mitotic entry but not enough checkpoint
activation to detect by phospho-Chk1 immunoblotting.
We then assessed whether cyclin A2’s role in chromatin
condensation might be mediated by cyclin B1-Cdk1, whose
nuclear accumulation and activation is regulated by cyclin
A2 (Fung et al., 2007; Gong et al., 2007; De Boer et al., 2008).
Knocking down cyclin B1 alone caused a small delay in
chromatin condensation, and it caused a marked delay in a
cyclin A2-knockdown background (Figure 1), consistent
with the idea that both cyclin A2 and cyclin B1 can support
chromatin condensation. By examining individual cells we
found that chromatin condensation commences when cyclin
B1 begins to accumulate in the nucleus (Figure 5), putting
cyclin B1 in the proper location to bring about chromatin
condensation and demonstrating that the cyclin B1 nuclear
translocation and chromatin condensation are tightly linked.
This ﬁnding agrees with recent results from Gavet and Pines
showing that cyclin B1-Cdk1 activation, as monitored with a
FRET reporter, is tightly associated with cyclin B1-Cdk1
nuclear translocation and chromatin condensation (Gavet
and Pines, 2010a, b). Expression of a constitutively-nuclear
form of cyclin B1 rescues chromatin condensation in cyclin
A2 knockdown cells (Figure 6), indicating that nuclear cyclin
B1-Cdk1 complexes can support chromatin condensation in
the absence or near-absence of cyclin A2.
There are at least three plausible models consistent with
these observations. The ﬁrst is that cyclin B1-Cdk1 is the
normal initiator of chromatin condensation, with cyclin A2
being required because it is necessary for the activation and
nuclear accumulation of cyclin B1-Cdk1 complexes. That is,
cyclin A2-Cdk is exclusively a primer kinase, and cyclin
B1-Cdk1 is an effector kinase. This model is compatible with
recent live cell imaging studies of Cdk1 activation that em-
phasize the tight temporal correlation between cyclin B1-
Cdk1 activation and chromatin condensation (Gavet and
Pines, 2010a, b) and with the evidence shown here of the
tight correlation between cyclin B1-Cdk1 translocation and
chromatin condensation. It also ﬁts well with the biochem-
ical identiﬁcation of cyclin B1-Cdk1 as M-phase promoting
factor in frog eggs and marine invertebrate eggs (Dunphy et
al., 1988; Lohka et al., 1988; Labbe et al., 1989). The main
evidence against this model is the relatively modest delay in
chromatin condensation seen in cyclin B1 knockdown cells.
However, there are several possible ways to rationalize this
modest delay: the small residual levels of cyclin B1 present
Figure 8. The spindle assembly checkpoint
arrest is compromised in cyclin B1 and cyclin
B1/B2 knockdown cells. (A–D) HeLa cells were
synchronized by double thymidine block, trans-
fected with the mitotic biosensor (MBS) plus
various d-siRNAs, and released into growth
media containing 100–200 ng/ml nocodazole.
(A) Timing of nuclear envelope breakdown
(NEB) in GL3 or cyclin knockdown cells in the
presence of nocodazole. (B) Final % of mitotic
cells that exited mitosis and reformed their nu-
clear envelopes. (C and D) The duration of mi-
tosis in control and cyclin knockdown cells
treated without (C) or with (D) nocodazole in
the growth media.
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condensation, or the cyclin A2-Cdk complexes could pro-
vide a back-up function.
The second model is that cyclin A2 normally triggers both
cyclin B1-Cdk1 activation/translocation and chromatin con-
densation, but the former is not required for the latter. In this
model, cyclin A2 is both a priming kinase and an effector
kinase for early mitotic events, whereas cyclin B1 is an
effector kinase only for late mitotic events. Consistent with
this model, we did see some cells where chromatin conden-
sation began before any detectable cyclin B1 translocation
(Figure 5), but there was too much uncertainty in the exper-
imental data to rule out the possibility that some small
amount of cyclin B1 was always present in the nucleus at the
time of chromatin condensation.
The third model, which we favor (Figure 9), is a hybrid of
the ﬁrst two. Cyclin A2 triggers cyclin B1-Cdk1 activation/
translocation, and the nuclear cyclin B1-Cdk1 and cyclin A2
complexes cooperate to bring about early mitotic events like
chromatin condensation and NEB. This model accounts for
all of our experimental observations, including the relatively
mild delays in chromatin condensation (this work) and NEB
(Gong et al., 2007) seen in cyclin B1-knockdown cells, and the
near-abolition of both events in cyclin A2/B1-double knock-
down cells. This model is also supported by recent studies of
HeLa cell extracts (Deibler and Kirschner, 2010). These ex-
tracts carry out Cdk activation and NEB in vitro (Deibler and
Kirschner, 2010) and are more amenable to biochemical dis-
section than intact cells. Deibler and Kirschner have found
that in HeLa cell extracts, cyclin A2 synergizes with fully-
active cyclin B1-Cdk1 to promote NEB (Deibler and Kirsch-
ner, 2010), in strong support of the hybrid model.
Notable motif-level features of this hybrid model (Figure
9) include feed-forward regulation (cyclin A2 promotes
chromatin condensation and NEB both directly and through
the intermediacy of cyclin B1-Cdk1), interlinked feedback
loops, and reciprocal regulation (Cdk1 activates Cdc25 and
inactivates Wee1; DNA damage activates Wee1 and inacti-
vates Cdc25). Modeling studies and quantitative experimen-
tal studies in Xenopus egg extracts argue that these features
help generate a robust, bistable mitotic trigger (Novak and
Tyson, 1993; Pomerening et al., 2003; Sha et al., 2003; Ferrell,
2008). In many ways, the triggering of mitosis in HeLa cells
is more complicated than it is in Xenopus extract. For exam-
ple, the timing of mitosis is determined by the rate of cyclin
B synthesis in Xenopus extracts and embryo (Hartley et al.,
1996), but not in somatic cells (Jin et al., 1996; Jin et al., 1998).
In addition, Cdk1 appears to increase in activity more grad-
ually in HeLa cell extracts than it does in Xenopus extracts
(Deibler and Kirschner, 2010). Finally, there are checkpoints
present in somatic cells that are inoperative in Xenopus ex-
tracts and embryos (Dasso and Newport, 1990; Minshull et
al., 1994). The systems-level motifs shown in Figure 9 may
contribute to the robustness of the more complicated so-
matic cell mitotic trigger, or, alternatively, they may be
vestiges of the simpler embryonic cell cycle oscillator circuit.
We also addressed the question of whether cyclins B1 and
B2 might be more critical for later steps in mitosis. Knocking
down cyclin B1 and B2 has been reported to cause qualita-
tive defects in mitotic progression (Gong et al., 2007). How-
ever, mitosis is normally fairly brief in HeLa cells, and there
is only a short time between when cyclin A2 is degraded (in
prometaphase) and when cyclins B1 and B2 are degraded (in
metaphase). This may explain why cyclin A2 can cover for
cyclins B1 and B2 fairly well in an unperturbed mitosis.
Mitosis can be lengthened or arrested by adding microtu-
bule-disrupting agents like nocodazole. It seemed plausible
that a requirement for B1/B2 function might be more ap-
parent in the spindle assembly checkpoint arrest than it is in
an unperturbed mitosis. Indeed, this was the case: nocoda-
zole-treated cyclin B1 knockdown cells were defective in
maintaining the mitotic state, and cyclin B1/B2 double
knockdown cells were more severely defective (Figures 7
and 8). This result was not unexpected; nevertheless, given
how unexpectedly subtle the early mitotic phenotypes were
in cyclin B1/B2 knockdown cells, it was nice to obtain a
result that conformed to expectations.
The cyclin B1 knockdown phenotypes seen here and in
our previous work (Gong et al., 2007) are weaker than those
reported by Fung and coworkers (Fung et al., 2007). There
are several possible explanations for this discrepancy. It is
possible that Fung et al. achieved a more complete cyclin B1
knockdown than we did, although from the cyclin B1 blots
shown in the three papers this did not appear to be the case.
It is possible that the shRNA constructs used by Fung and
coworkers produced off-target effects or caused a general
Figure 9. Schematic view of the hypothe-
sized roles of cyclin A2 and cyclin B1 in the
regulation of early and late mitotic events.
Based on recent studies of HeLa cell extracts
(Deibler and Kirschner, 2010), we assume that
Cdk1 is the relevant cyclin A2-associated
Cdk.
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ways (Grimm et al., 2006), and that this contributed to the
stronger phenotype they reported. It is also possible that
cyclin A2 can cover the functions of cyclin B1 and B2 to
differing extents in different cell lines (even in different HeLa
cell lines). Whatever the explanation, our work shows that
cyclin A2 is the single most vulnerable cyclin target for the
disruption of M-phase, and that knocking down cyclins A2
and B1 together synergistically disrupts M-phase. These
ﬁndings could be of interest in developing antimitotic ther-
apeutic agents.
The present studies point toward the importance of cyclin
A2 in early mitotic events and underscore the many unan-
swered questions about the regulation of cyclin A2 com-
plexes. When, exactly, are the cyclin A2 complexes acti-
vated? And what brings about their activation? Is their
activation triggered simply by the accumulation of cyclin A2
to a threshold level (probably not, because cyclin A2 over-
expression does not accelerate mitotic entry [Figure 2]), or
the release of the CDK regulators Wee1 and Cdc25 from
control by the DNA replication checkpoint, or something
else? Answers to these questions will be important for un-
derstanding how the initiation of mitosis is tied into the
earlier events of the cell cycle.
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